Atossa intends to submit the information and data to the FDA on or before August 20, 2014. So, this should be done or nearly done. If it takes 30days for FDA to review the data. then we should see the results by early Oct.
Something is coming. If relaunch the device, we would see $5 again. Depends on if FDA gives clearance or not. As least the company said they are working toward that goal.
You should phrase like that: eBay screws the BAD sellers yet again. oh yeah, good move. Think that if buyers are hesitating, Will you see any transactions?
Apparently, the problem is the management. They should have better communications with the investment community so that more people can recognize its value. The company is not doing anything even after the panel meeting (surprisingly). Secondly, the company's way of raising cash is kind of stupidest. Whoever will use ATM to raise cash if getting better way to do it? Not any investment institution will put any long time money in if the company keeps selling stock on the market. (ATM). At least, this company needs a better IR department.
How can one CEO handle two completely businesses well simultaneously?
The last two years just showed that while paypal is growing well but e-auction stayed behind.
Paypal has to go alone and let it grow faster, not under the hood of EBAY.
No offense, just tell the truth.
QQQ went from $50s from 2013 to $98 and EBAY stays negative for the same time period. Something must be wrong, period.
CEO and his team runs out of tricks. The last rabbit was pulled out and no more left. So BOD should search for a new leader for the company.
If you check the background of CEO, it is easy to know what style the CEO is and how he built his empire. It is way overdue to refresh the leadership. Wish this is not too long time waiting.
If CEO keeps doing this. SO much under-performing the market. Something must be done to remove the CEO.
Finally, someone gets similar opinion like I just posted yesterday.
IMHO, the management is more looks like lack expertise in handling such cancer drugs. The evidence is they just forced out the SV of Dev. And temporarily appointed another one who might do not have the expertise either. Therefore, it get Dr. T in. Eventually, Dr. T might overlook all the drugs unless the company finds another one who qualifies the job.
Another which also obvious is that CEO does not qualify either. Otherwise, how could he appoint the former SV Dev. and trial was not properly designed in case of adverse effects exits such data should be collected immediately.
Looks like Dr.T comes for rescue but eventually current top executives should be replaced in order to get the drugs through FDA approval.
The only thing that can be looked positively is that the company confirmed it will not initiate any new trial even after assuming the sponsorship of Imetelstat. This showed some confidence from company the hold will be lifted eventually. Otherwise it makes no sense to assume the sponsorship at this moment.
The problem is the 'IF's. The management said the stock distribution will be done in July. But today it said that will be done in the next several weeks. No credibility at all.
If we can get data, does he implied that they even have not gotten data? Then what they had been doing in the last five months?
Comparing that Mayo had responded and removed the hold in June (two months ago),
I highly doubt even after the hold being removed in the unpredictable future, current management will be able to bring this through FDA approval.
So, BOD should consider either sell the company or replace the top management ASAP!
I just repeated what I posted this morning with additional notes.
1. Why it could not provide data to satisfy FDA, instead, mayo did and get partial lift of the hold. (still compiling data)
2. It is normal to have PR when the data is provided to FDA, so far nothing. (True : nothing yet)
3. why the SV Dev is forced out?
4. Originally, it said the shares are to be distributed in July. Now it is Aug. 15th. (True: in the next several weeks. Yup, just several more weeks, longer waiting)
5. If it's not because of quarterly report, probably GERN will never update anything. Actually, what will be given to investor this afternoon is still big question mark. (True, because no progress to be posted)
CEO just proved what I said this morning.
BTW, once the top management is not competent, they are highly to ruin a very good product. See what happened to CHTP (which was bought out recently). It was ruined by its management initially. But later the BOD removed the CEO and others, the new CEO brought the same drug being approval by FDA within a year.
I strongly suggest the changing of management. the hold process is enough for the company to make a change. Otherwise, investors will lose even bigger bc of them